All In Biotech

Drugs by condition

Drugs approved for rheumatoid arthritis

Brand-name prescription drugs and biologics whose FDA label lists rheumatoid arthritis as an approved use. Matched on the label phrases: "rheumatoid arthritis".

Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

75

Still marketed, NDA or BLA

Drug classes

16

Novel drugs

23

New molecular entities and new biologics

In development

34

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for rheumatoid arthritis.

  • Avtozma (Tocilizumab-Anoh) · Celltrion INC Jan 21, 2026
  • Vyscoxa (Celecoxib) · Carwin Pharm Assoc Jul 29, 2025
  • Tyenne (Tocilizumab-Aazg) · Fresenius Kabi USA Mar 14, 2025
  • Avtozma (Tocilizumab-Anoh) · Celltrion INC Jan 24, 2025
  • Rinvoq Lq (Upadacitinib) · Abbvie OrphanApr 26, 2024

All approved drugs for rheumatoid arthritis, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 377 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Tumor Necrosis Factor Blocker (12)

  • Simponi Golimumab · Centocor Ortho Biotech INC · 2009
  • Cimzia Certolizumab Pegol · Ucb INC · 2008
  • Enbrel Etanercept · Immunex · 1998
  • Remicade Infliximab · Centocor INC · 1998
  • Yusimry Adalimumab-Aqvh · Emerge Bioscience Pte LTD · 2021
  • Avsola Infliximab-Axxq · Amgen INC · 2019
  • Hadlima Adalimumab-Bwwd · Samsung Bioepis CO LTD · 2019
  • Hyrimoz Adalimumab-Adaz · Sandoz INC · 2018
  • Renflexis Infliximab-Abda · Samsung Bioepis CO LTD · 2017
  • Amjevita Adalimumab-Atto · Amgen INC · 2016
  • Inflectra Infliximab-Dyyb · Celltrion INC · 2016
  • Simponi Aria Golimumab · Janssen Biotech · 2013

Interleukin-6 Receptor Antagonist (8)

  • Kevzara Sarilumab · Sanofi Synthelabo · 2017
  • Actemra Tocilizumab · Genentech · 2010
  • Avtozma Tocilizumab-Anoh · Celltrion INC · 2026
  • Tyenne Tocilizumab-Aazg · Fresenius Kabi USA · 2025
  • Avtozma Tocilizumab-Anoh · Celltrion INC · 2025
  • Tyenne Tocilizumab-Aazg · Fresenius Kabi USA · 2024
  • Tofidence Tocilizumab-Bavi · Biogen Ma · 2023
  • Actemra Tocilizumab · Genentech · 2013

Nonsteroidal Anti-inflammatory Drug (8)

  • Celebrex Celecoxib · Upjohn · 1998
  • Vyscoxa Celecoxib · Carwin Pharm Assoc · 2025
  • Coxanto Oxaprozin · Solubiomix · 2023
  • Meloxicam Meloxicam · Avondale Pharms · 2004
  • Ec-Naprosyn Naproxen · Atnahs Pharma US · 1994
  • Naprosyn Naproxen · Atnahs Pharma US · 1987
  • Indocin Indomethacin · Cosette · 1985
  • Indomethacin Indomethacin · Chartwell Molecules · 1984

CD20-directed Cytolytic Antibody (4)

  • Rituxan Rituximab · Genentech · 1997
  • Riabni Rituximab-Arrx · Amgen INC · 2020
  • Ruxience Rituximab-Pvvr · Pfizer INC · 2019
  • Truxima Rituximab-Abbs · Celltrion INC · 2018

Corticosteroid (4)

  • Medrol Methylprednisolone · Pfizer · 1957
  • Kenalog-40 Triamcinolone Acetonide · Apothecon · 1965
  • Kenalog-10 Triamcinolone Acetonide · Apothecon · 1960
  • Cortef Hydrocortisone · Pharmacia and Upjohn · 1952

Janus Kinase Inhibitor (3)

  • Rinvoq Upadacitinib · Abbvie · 2019
  • Olumiant Baricitinib · Eli Lilly and CO · 2018
  • Rinvoq Lq Upadacitinib · Abbvie · 2024

Antirheumatic Agent (3)

  • Arava Leflunomide · Sanofi Aventis US · 1998
  • Cuprimine Penicillamine · Valeant Pharms Intl · 1970
  • Depen Penicillamine · Mylan Speciality Lp · 1978

Calcineurin Inhibitor Immunosuppressant (2)

  • Neoral Cyclosporine · Novartis · 1995
  • Neoral Cyclosporine · Novartis · 1995

Adrenocorticotropic Hormone (2)

Selective T Cell Costimulation Modulator (1)

  • Orencia Abatacept · Bristol Myers Squibb · 2005

Interleukin-1 Receptor Antagonist (1)

  • Kineret Anakinra · Biovitrum Ab · 2001

Purine Antimetabolite (1)

  • Imuran Azathioprine · Legacy · 1968

Aminosalicylate (1)

Folate Analog Metabolic Inhibitor (1)

  • Jylamvo Methotrexate · Shorla · 2022

Prostaglandin E1 Analog (1)

  • Arthrotec Diclofenac Sodium, Misoprostol · Pfizer · 1997

Class not listed in FDA's data (23)

  • Xeljanz Tofacitinib Citrate · Pf Prism Cv · 2012
  • Humira Adalimumab · Abbvie INC · 2002
  • Syprine Trientine Hydrochloride · Bausch · 1985
  • Ridaura Auranofin · Legacy · 1985
  • Celestone Soluspan Betamethasone Acetate, Betamethasone Sodium Phosphate · Organon · 1965
  • Plaquenil Hydroxychloroquine Sulfate · Advanz Pharma · 1955
  • Simlandi Adalimumab-Ryvk · Alvotech USA INC · 2024
  • Idacio Adalimumab-Aacf · Fresenius Kabi USA · 2024
  • Yuflyma Adalimumab-Aaty · Celltrion · 2023
  • Sovuna Hydroxychloroquine Sulfate · Novitium Pharma · 2022
  • Xeljanz Tofacitinib Citrate · Pfizer · 2020
  • Hulio Adalimumab-Fkjp · Mylan Pharms INC · 2020
  • Abrilada Adalimumab-Afzb · Pfizer INC · 2019
  • Cyltezo Adalimumab-Adbm · Boehringer Ingelheim · 2017
  • Xeljanz Xr Tofacitinib Citrate · Pfizer · 2016
  • Rasuvo Methotrexate · Medexus · 2014
  • Orapred Odt Prednisolone Sodium Phosphate · Advanz Pharma · 2006
  • Naprelan Naproxen Sodium · Twi Pharms · 1996
  • Pediapred Prednisolone Sodium Phosphate · Pai Holdings · 1986
  • Methotrexate Preservative Free Methotrexate Sodium · Hospira · 1959
  • Depo-Medrol Methylprednisolone Acetate · Pfizer · 1959
  • Solu-Medrol Methylprednisolone Sodium Succinate · Pharmacia and Upjohn · 1959
  • Solu-Cortef Hydrocortisone Sodium Succinate · Pharmacia and Upjohn · 1955

Drugs in development for rheumatoid arthritis

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • IanalumabVAY736, VAY736 AIPhase 318 trials

    Novartis · Primary Immune Thrombocytopenia (ITP), Systemic Lupus Erythematosus, Sjogren Syndrome

  • AfimkibartRO7790121, RVT-3101Phase 312 trials

    Roche (Genentech) · Moderately to Severely Active Ulcerative Colitis, Moderately to Severely Active Crohns Disease, Atopic Dermatitis

  • LutikizumabABT-981Phase 38 trials

    AbbVie · Hidradenitis Suppurativa, Atopic Dermatitis, Rheumatoid Arthritis

  • TLL-018Phase 38 trials

    Hangzhou Highlightll Pharmaceutical Co., Ltd · Chronic Spontaneous Urticaria (CSU), Rheumatoid Arthritis, Chronic Spontaneous Urticaria

  • IMVT-1402Phase 37 trials

    Immunovant Sciences GmbH · Graves' Disease, Rheumatoid Arthritis, Subacute Cutaneous Lupus Erythematosus

  • FilgotinibGS-6034, GLPG0634Phase 36 trials

    Alfasigma S.p.A. · Ulcerative Colitis, Polyarticular Course Juvenile Idiopathic Arthritis, Juvenile Idiopathic Arthritis (JIA)

  • LNK01001Phase 33 trials

    Lynk Pharmaceuticals Co., Ltd · Ankylosing Spondylitis, Atopic Dermatitis, Rheumatoid Arthritis

  • Beijing VDJBio Co., LTD. · Anti IL-6R, Idiopathic Multicentric Castleman's Disease, Castleman's Disease, Multicentric

  • ABBV-722Phase 32 trials

    AbbVie · Rheumatoid Arthritis, Systemic Sclerosis

  • LevilimabPhase 31 trial

    Biocad · Rheumatoid Arthritis

  • mAbxience Research S.L. · Rheumatoid Arthritis (RA)

  • rapcabtagene autoleucelYTB323Phase 28 trials

    Novartis · Lupus Nephritis, Rheumatoid Arthritis (RA) and Sjögren's Disease (SjD), ANCA Associated Vasculitis (AAV)

  • AP1189Phase 23 trials

    SynAct Pharma Aps · Rheumatoid Arthritis (RA), Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy, Severe Proteinuria Due to Idiopathic Membranous Nephropathy

  • GenSci048Phase 23 trials

    Changchun GeneScience Pharmaceutical Co., Ltd. · Uveitis, Systemic Sclerosis Associated Interstitial Lung Disease, Rheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD)

  • QLS12010Phase 23 trials

    Qilu Pharmaceutical Co., Ltd. · Adults With Moderate-to-severe Hidradenitis Suppurativa, Moderate-to-severe Atopic Dermatitis, Rheumatoid Arthritis (RA)

  • CIT-013Phase 22 trials

    Citryll BV · Hidradenitis Suppurativa (HS), Rheumatoid Arthritis

  • CIT-013 dosePhase 22 trials

    Citryll BV · Hidradenitis Suppurativa (HS), Rheumatoid Arthritis

  • JAB-8263Phase 22 trials

    Jacobio Pharmaceuticals Co., Ltd. · Rheumatoid Arthritis (RA), NSCLC, SCLC

  • NKX019Phase 22 trials

    Nkarta, Inc. · Lupus Nephritis, Primary Membranous Nephropathy, Systemic Sclerosis

  • RosnilimabANB030Phase 22 trials

    AnaptysBio, Inc. · Rheumatoid Arthritis, Ulcerative Colitis

1 discontinued brand-name drugs whose label still names it

More on rheumatoid arthritis: recruiting trials · published research

Related in immunology and inflammation: Plaque psoriasis · Psoriatic arthritis · Atopic dermatitis (eczema) · Crohn's disease · Ulcerative colitis · Ankylosing spondylitis · Lupus (SLE) · Hidradenitis suppurativa · Chronic hives (urticaria) · Alopecia areata

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.